Synthon Chile is a commercial minded organization of almost 50 professionals from different backgrounds oriented to serve local pharma ecosystem.

Chile Santiago
Research, development, production and direct-to-market sales
At a glance
The plant has been GMP approved by both the Chilean and European health authorities.
With its 350 employees, the site handles over 50 different products (molecules/strengths) from both the local and Synthon's global portfolio.
Our Chilean site is the first drug product manufacturing plant in Chile to obtain approval by an EU health authority to manufacture products for the EU market.
More than 300 customers are being served on a monthly basis in Chile
300.000 units are delivered monthly



.jpg)
People make the difference
Richard Nevares
Read the Latest news
Research and Development & Drug Product Manufacturing and Direct-to-market Sales
Valle Grande Lampa,
Santiago
Working together for patients worldwide
Our mission is to create access to high-quality generic medicines for all patients. We believe in our trusted partnerships to achieve our goals. If you would like to discuss partnering opportunities, get in touch.